drugset / Trial / NCT00383188
An Oral p38 Inhibitor Investigating Safety, Efficacy, And PK In Subjects With Active Rheumatoid Arthritis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Investigating the safety and tolerability of a p38 inhibitor as monotherapy in subjects who have failed at least 1 DMARD.
Timeline
- Start
- 2006-12-15
- Primary completion
- 2008-07-01
- Completion
- 2008-07-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PH-797804 | Small molecule | 0.5 mg | Oral |
| Subject | PH-797804 | Small molecule | 3 mg | Oral |
| Subject | PH-797804 | Small molecule | 6 mg | Oral |
| Subject | PH-797804 | Small molecule | 10 mg | Oral |